跳至主要内容
临床试验/JPRN-jRCTs061220053
JPRN-jRCTs061220053招募中2 期

A pilot study of low-concentration hydrogen peroxide exposure radiotherapy for low radiosensitive tumors and bulky tumors that are unresectable and ineligible for standard chemotherapy

Tamaki Yukihisa0 个研究点目标入组 10 人开始时间: 2022年8月30日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Histologically diagnosed as Non-Hematologic Malignancies
  • 2. It satisfies one of the following
  • Low radiosensitive tumors (adenocarcinoma, sarcoma, melanoma, hepatocellular carcinoma, renal cell carcinoma)
  • Bulky tumor >= 5cm (regardless of radiosensitivity)
  • 3. Unresectable malignant tumor
  • 4. Ineligible for standard chemotherapy and no alternative curative treatment
  • 5. Measurable lesions exist
  • 6. Age 20 years or older on the date of informed consent
  • 7. ECOG performance status (PS) of 0-3.
  • 8. The latest laboratory test within 28 days prior to enrollment
  • a. WBC >=2000/micro L
  • b. Platelet >=50000 / micro L
  • c. Total bilirubin <=3.0 mg/dL
  • d. AST <=150 U/L
  • e. ALT <=150 U/L
  • f. SpO2 (room air) >=90%
  • 9. Written informed consent

排除标准

  • 1. Hypersensitivity to hydrogen peroxide, sodium hyaluronate, Lidocaine or amide type local anesthetic
  • 2. Uncontrollable infection
  • 3. Disseminated intravascular coagulation
  • 4. Unable to maintain the rest position for 20 minutes
  • 5. Pregnant or possibly pregnant woman, or man who wants pregnancy of his partner
  • 6. Psychological disorder difficult to participate in the study
  • 7. Interstitial lung disease or Pulmonary fibrosis

研究者

发起方
Tamaki Yukihisa

相似试验